Modern approaches to pretransfusion testing

Immunohematology

Volumn 15, Issue 1, 1999, Pages 41-52

  John Judd, W ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROGOL;

ANTIBODY DETECTION; BIOTECHNOLOGY; BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RH; BLOOD SAMPLING; BLOOD TRANSFUSION; COLUMN CHROMATOGRAPHY; CONFERENCE PAPER; HUMAN; LABORATORY TEST; PRIORITY JOURNAL;

EID: 0032988112     PISSN: 0894203X     EISSN: 19303955     Source Type: Journal    
DOI: 10.21307/immunohematology-2019-610     Document Type: Article

References (63)

1. Oberman HA. Judd WJ. Cost-containment in transfusion practice: A view from the United States. In: Cash JD, ed. Progress in transfusion medicine. 3rd ed. Edinburgh, Scotland: Churchill Livingstone, 1988:145-58.
2. Smith DM, Judd WJ, eds. Blood banking in a changing environment. Arlington, VA: American Association of Blood Banks, 1984.
3. Issitt PD. The impact of monoclonal antibodies in blood group serology. Transfusion 1989;29:58-64.
4. Nance SJ, Garratty G.A new potentiator of red blood cell antigen-Antibody reactions. Am J Clin Pathol 1987;87:633-5.
5. Plapp FV, Sinor LT, Rachel JM, et al. A solid phase antibody screen. Am J Clin Pathol 1984;82:719-21.
6. Lapierre Y Rigal D, Adam J, et al. The gel test: A new way to detect red cell antigen-Antibody reactions. Transfusion 1990;30:109-13.
7. Butch SH, Judd WJ, Steiner EA, Stoe M, Oberman HA. Electronic verification of donor-recipient compatibility: The computer crossmatch. Transfusion 1994; 34:105-9.
8. Shulman IA. Comprehensive transfusion medicine survey J-B [final critique]. Northfield, IL: College of American Pathologists; 1985.
9. Sazama KS, Shulman IA. Transfusion medicine (comprehensive, limited) survey set J-A [final critique]. Northfield, IL: College of American Pathologists; 1998.
10. Maffei LM, Johnson ST, Shulman IA, Steiner EA. Pretransfusion testing survey. Transfusion 1998; 38:343-9.
11. Judd WJ, Butch SH. Cost-containment in the blood bank: eliminating unnecessary serological testing. J MedTechnol 1984;1:484-95.
12. Garratty G. The significance of complement in immunohematology. CRC Crit Rev Clin Lab Sci 1984;20:25-56.
13. Low B, Messeter L. AHG tests in low-ionic strength salt solutions for rapid antibody screening and crossmatching. Vox Sang 1974;26:53-61.
14. Mołlison PL. Blood transfusion in clinical medicine. 5th ed. Oxford, England: Blackwell Scientific Publications, 1972.
15. Issitt PD. Antibodies reactive at 30° centigrade, room temperature and below: A technical workshop. In: Butch SH, ed. Clinically significant and insignificant antibodies: A technical workshop. Washington, DC: American Association of Blood Banks, 1979:13-28.
16. Wright MS, Issitt PD. Anticomplement and the indirect AHG test. Transfusion 1979;19:688-94.
17. Howard JE, Winn LC, Gottlieb CE, Grumet FC, Garratty G, Petz LD. Clinical significance of the anticomplement component of AHG antisera. Transfusion 1982;22:269-72.
18. Judd WJ, Butch SH, Oberman HA, Steiner EA, Bauer RC. The evaluation of a positive direct AHG test in pretransfusion testing. Transfusion 1980;20:17-23.
19. Judd WJ, Barnes BA, Steiner EA, Oberman HA, Averill DB, Butch SH. The evaluation of a positive direct AHG test in pretransfusion testing revisited. Transfusion 1986;26:220-4.
20. Oberman HA, Barnes BA, Friedman BA. The risk of abbreviating the crossmatch in urgent or massive transfusion. Transfusion 1978; 18:137-41.
21. Oberman HA, Barnes BA, Steiner EA. Role of the crossmatch in testing for serologic incompatibility. Transfusion 1982;22:12-6.
22. Judd WJ. Testing for unexpected red cell antibodies-Two or three reagent red cell samples. Immunohematology 1997;13:90-2.
23. Shulman IA, Nelson JM, Okamoto M, Malone SA. The dependence of anti-Jka detection on screening cell zygosity. Lab Med 1985;16:602-4.
24. Shulman IA, Yaowasiriwatt M, Saxena S, Nelson JM. Influence of reagent red cell zygosity on anti-Fy1 detection. Lab Med 1989; 20:37-9.
25. Fitzsimmons JM, Morel PA. The effects of red blood cell suspending media on hemagglutination and the AHG test. Transfusion 1979;19:81-5.
26. Boral LI, Henry JB. The type and screen: A safe alternative and supplement in selected surgical blood order schedules. Transfusion 1977;17:163-8.
27. Friedman BA, Oberman HA, Chadwick AR, Kingdon KI. The maximal surgical blood order schedule and surgical blood use in the United States. Transfusion 1976;16:380-7.
28. Garratty G. The role of compatibility tests (rapid communication). Transfusion 1982;22:169-72.
29. Food and Drug Administration. FDA memorandum to all registered blood establishments: equivalent methods for compatibility testing. December, 1984.
30. Code of federal regulations. Current edition. Title 21. Subparts 606 and 640. Washington, DC: U.S. Government Printing Office.
31. Menitove J, ed. Standards for blood banks and transfusion services. 18th ed. Bethesda, MD: American Association of Blood Banks, 1998.
32. Judd WJ, Steiner EA, Oberman HA, Nance SJ. Can the reading for serological reactivity following 37°C incubation be omitted? Transfusion 1992;32:304-8.
33. JuddWJ, Steiner EA, KnafI PC. The gel test: sensitivity and specificity for unexpected antibodies to blood group antigens. Immunohematology 1997;13:132-5.
34. Vengelen-Tyler V, ed. Technical manual. 12th ed. Bethesda, MD:American Association of Blood Banks, 1996.
35. Judd WJ, Fullen DR, Steiner EA, Davenport RD, KnafI PC. Revisiting the issue: can the reading for serologic reactivity following 37°C incubation be omitted? Transfusion (in press).
36. Beck ML, Yates AD, Hardman J, Kowalski MA. Identification of a subset of group B donors identified with a monoclonal anti-A reagent. Am J Clin Pathol 1989;92:625-9.
37. Beck ML, Kowalski MA, Kirkegaard JR, Korth JL. Unexpected reactivity with monoclonal anti-B reagents. Immunohematology 1992;8:22-3.
38. JuddWJ, Steiner EA, Oberman HA, Giacherio D. Falsepositive results with chemically modified anti-D do not indicate the need for a separate immunologically inert Rh control reagent. Transfusion 1988;28: 339-41.
39. Judd WJ. Methods in immunohematology. 2nd ed. Durham, NC: Montgomery Scientific Publications, 1994.
40. Champagne K, Spruell P, Chen J, et al. Comparison of affinity column technology and USS tube tests. Immunohematology 1998;14:149-51.
41. Judd WJ, Steiner EA, O'Donnell DB, Oberman HA. Discrepancies in ABO typing due to prozone: how safe is the immediate-spin crossmatch? Transfusion 1988;28:334-8.
42. Voak D. Observations on the rare phenomenon of anti-A prozone and the non-specific blocking of hemagglutination due to Cl complement fixation of IgG anti-A antibodies. Vox Sang 1972;22:408-19.
43. Judd WJ.'New' blood bank technologies. Clin Lab Sci 1998;11:106-13.
44. Reilly B, DePalma H, Cosgrove P, Parsi M, Grima K. Comparison between routine tube test (LISS), PEG tube test, gel technology and solid-phase red cell adherence assays (abstract). Transfusion 1997; 37:648.
45. Issitt PD, Combs MR, Bradshaw T. Comparison of a solid phase and polyethylene' glycol (PEG) IAT method in a large transfusion service (abstract). Transfusion 1997;37:28S.
46. Allen J, Issitt PD, Combs MR. Detection of weak complement-binding antibodies in polyethylene glycol (PEG>IATs read with anti-IgG service (abstract). Transfusion 1997;37:28S.
47. Alkahasan AA, Combs MR, Issitt PD. Detection of 37°C agglutinins by polyethylene glycol (PEG>IAT (abstract). Transfusion 1997;37:28S.
48. Issitt PD, Combs MR, Booth K. Comparison of the MTS-gel and polyethylene glycol (PEG) IAT methods (abstract). Transfusion 1997;37:64S.
49. Lown J, Willis J. Monocyte monolayer assay (MMA) reactivity of alloantibodies reacting by the manual polybrene technique but not by an antiglobulin test. Transfus Med 1995;5:281-4.
50. Garratty G. Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, eds. Clinical and serological aspects of transfusion reactions. Arlington, VA: American Association of Blood Banks, 1982:91-119.
51. Lalezari P Jiang AF. The manual Polybrene® test: A simple and rapid procedure for detection of red cell antibodies. Transfusion 1980;20:206-11.
52. Judd WJ. Requirements for the electronic crossmatch. Vox Sang 1998;74(S2):409-17.
53. Judd WJ. The electronic crossmatch: An alternative to the immediate-spin crossmatch to detect ABO incompatibility. Advance 1998;10(15):16-23.
54. Sawfenberg J, Hogman CF, Cassemar B. Computerized delivery control-A useful and safe complement to the type and screen compatibility testing. Vox Sang 1997;72:162-8.
55. Cox C, Enno A, Deveridge S, et al. Remote electronic release blood system. Transfusion 1997;37:960-4.
56. ChanA, Chan JC,Wong LY Cheng G. From maximum surgical blood ordering schedule to unlimited computer crossmatching: evolution of blood transfusion for surgical patients at a tertiary hospital in Hong Kong. Transfus Med 1996;6:121-4.
57. British Committee for Standardization in Haematology, Blood Transfusion Task Force. Guidelines for pre-Transfusion compatibility procedures in blood transfusion laboratories. Transfus Med 1996;6:273-83.
58. Georgsen J, Jensen F, Jeppesen S, Rasmussen L, Kristensen T. Transfusion service of the county of Funen. Organizational and economic aspects of restructuring. Ugeskrift for Laeger 1997; 159:1758-62.
59. Barratt PG, Russel PG, Rowell JA. Eighteen months experience with a "computer crossmatch"-minus the computer (abstract). Transfusion 1993;33:748.
60. Computer Crossmatch Reviewer's Checklist. U.S. Food and Drug Administration's Center for Biologies Evaluation and Research. Rockville, MD; 1997.
61. Steane EA, Steane SM, Montgomery SR, Pearson JR. A proposal for compatibility testing incorporating the manual hexadimethrine bromide (Polybrene®) test. Transfusion 1985;25:176-8.
62. Berry-Dortch S, Woodside C, Boral LI. Limitations of the immediate spin crossmatch when used for detecting ABO incompatibility. Transfusion 1985;25:540-4.
63. Triulzi DJ, Portman WH, Mango PD, Lopez-Plaza J, Hahn LF. Centralized transfusion service: A novel approach to the delivery of transfusion services. Transfus Med Rev 1995;9:123-30.